| Literature DB >> 12362520 |
Jason E Klein, Alan R Fleischman.
Abstract
Drug companies are moving their research from academic medical centers to physicians' private offices. The shift brings in more subjects, and could mean faster and better results. It also changes the physician's relationship to patients, dangles monetary lures in front of physicians, and could produce subjects who don't understand what they're participating in and results that are unreliable.Entities:
Keywords: Biomedical and Behavioral Research
Mesh:
Substances:
Year: 2002 PMID: 12362520
Source DB: PubMed Journal: Hastings Cent Rep ISSN: 0093-0334 Impact factor: 2.683